View Full Paper

Owner Consent Verified
Research Proposal 4.8

Pharmacovigilance and Governance And Risk among Fortune 500 Firms — Evidence from South Asia

24
Pages
IEEE
Style
~ 25–35 mins
Reading Time
Sociology FinTech BioMed
Abstract

This research proposal investigates “Pharmacovigilance and Governance And Risk among Fortune 500 Firms — Evidence from South Asia” using a panel regression with fixed effects. Through a socio-technical lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.

Download PDF Order Similar Paper Save

Pharmacovigilance and Governance And Risk among Fortune 500 Firms — Evidence from South Asia

ABSTRACT
Pharmacovigilance and Governance And Risk among Fortune 500 Firms — Evidence from South Asia is unpacked across themes: benefits, KPIs, costs, and change enablement. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
37 Pages 4.8
Talent And Skills in Hospitality Management for Esports Organizations: A benchmarking and maturity modeling
Sustainability MLOps Supply Chain
View Paper
34 Pages 4.9
Market Entry Strategy in Supply Chain Resilience for Healthcare Providers: A Comparative Perspective
Impact Psychology Cybersecurity
View Paper
36 Pages 4.3
Digital Twins Adoption in Logistics Hubs in Europe: Governance And Risk — Post-Pandemic Lessons
Epidemiology Cybersecurity Marketing
View Paper